Empresa Adaptimmune Therapeutics plc
Acciones
ADAP
US00653A1079
Biotecnología e investigación médica
Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,968 USD | +7,75 % | -16,55 % | +22,07 % |
Resumen de negocios
Número de empleados: 449
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Cell Therapies
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +122,05 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +122,05 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 57 | 01/01/08 | |
Adrian Rawcliffe
CEO | Chief Executive Officer | 52 | 01/03/15 |
Gavin Wood
DFI | Director of Finance/CFO | 54 | 01/04/20 |
Joanna Brewer
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/01/09 |
Elliot Norry
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/07/15 |
William Bertrand
COO | Chief Operating Officer | 59 | 15/03/17 |
Juli P. Miller
IRC | Investor Relations Contact | - | 01/08/16 |
Sharp Kerry
LAW | General Counsel | - | 01/10/15 |
Phil Bassett
PRN | Corporate Officer/Principal | - | - |
John Lunger
PRN | Corporate Officer/Principal | 55 | 01/03/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | 01/11 |
Andrew Allen
BRD | Director/Board Member | 57 | 01/06/23 |
David Mott
CHM | Chairman | 58 | 01/09/14 |
Adrian Rawcliffe
CEO | Chief Executive Officer | 52 | 01/03/15 |
Ali Behbahani
BRD | Director/Board Member | 47 | 01/09/14 |
Garry Menzel
BRD | Director/Board Member | 59 | 01/06/23 |
John Furey
BRD | Director/Board Member | 59 | 05/07/18 |
Lawrence Alleva
BRD | Director/Board Member | 74 | 01/03/15 |
Priti Hegde
BRD | Director/Board Member | 52 | 01/06/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 480 950 456 | 223 044 163 ( 15,06 %) | 0 | 15,06 % |
Información de la empresa
Adaptimmune Therapeutics Plc
60 Jubilee Avenue Milton Park
OX14 4RX, Abingdon
+44 12 3543 0000
http://www.adaptimmune.comSector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+22,07 % | 230 M | |
-3,34 % | 102 mil M | |
+1,72 % | 96,07 mil M | |
-1,80 % | 21,66 mil M | |
-17,75 % | 20,77 mil M | |
-6,91 % | 18,53 mil M | |
-42,00 % | 16,91 mil M | |
-27,80 % | 13,79 mil M | |
-0,84 % | 13,33 mil M | |
+19,67 % | 10,94 mil M |
- Bolsa de valores
- Acciones
- Acción ADAP
- Empresa Adaptimmune Therapeutics plc